Treatment with seralutinib (GB002), an inhaled investigational therapy, significantly improved measures of blood pressure in the lungs of people with…
Articles by Marisa Wexler, MS
Immune cells called eosinophils help protect against the progression of pulmonary hypertension (PH) by reducing lung inflammation and regulating…
Obstructive sleep apnea (OSA) is common among people with pulmonary hypertension (PH), and PH patients with OSA are more…
Step count and heart rate data from wearable sensors can be of use as real-world approximations of common clinical tests…
The experimental therapy HS135 improved heart function and the remodeling of lung blood vessels in a rat model of…
Premature newborns who are treated for eye problems with anti-VEGF therapies may be at increased risk of developing pulmonary…
The U.S. Food and Drug Administration (FDA) granted breakthrough device designation to the CorVista System, a point-of-care diagnostic tool that…
Switching from weekly infusions of levosimendan to a daily oral version of the experimental medication was well-tolerated among people with…
Treatment with sotatercept, given in addition to standard therapies, significantly improves exercise capacity in people with pulmonary arterial hypertension…
Two weeks of aerobic exercise improved blood flow parameters and survival in a rat model of pulmonary arterial hypertension…
A high dose of Tyvaso (inhaled treprostinil) — at least nine breaths four times per day — is more…
The U.S. Food and Drug Administration (FDA) has accepted a proposal from Bellerophon Therapeutics to reduce the size of a…